SereneRF for Soft Tissue Tumors

About Thermedical

Thermedical is a clinical-stage medical device company pioneering a novel thermal ablation platform for oncology and cardiology applications. Its core technology, SereneRF, utilizes low-flow, low-temperature radiofrequency energy to create large, predictable, and conformal ablation zones, potentially addressing limitations of existing ablation methods. The company is initially targeting challenging soft tissue tumors, such as pancreatic cancer, and cardiac arrhythmias like ventricular tachycardia. As a private, pre-revenue entity, Thermedical's progress hinges on successful clinical validation and strategic partnerships to advance its pipeline.

Therapeutic Areas

Other Pancreatic Cancer / Solid Tumors Drugs